Healthcare - Sector
Deciphera Pharmaceuticals LLC's activity chart (see below) currently has 139 price targets and 114 ratings on display.
Analysts' price targets on this stock were met 67.06% of the time, taking 209.38 days on average.
Most recent stock forecast was given by BRADLEY CANINO from GUGGENHEIM on 10-May-2024. First documented stock forecast 23-Oct-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 31-Oct-2023
$23
$23
2 years 6 months 12 days ago
(10-May-2024)
5/8 (62.5%)
$-2.36 (-9.31%)
108
Sell Since 04-Jan-2023
$26
2 years 6 months 23 days ago
(30-Apr-2024)
2/7 (28.57%)
$0.73 (2.89%)
324
Buy Since 30-Apr-2024
$22
2 years 6 months 23 days ago
(30-Apr-2024)
2/3 (66.67%)
$2.24 (11.34%)
67
Buy Since 29-Apr-2024
$25
$23
2 years 6 months 24 days ago
(29-Apr-2024)
16/26 (61.54%)
$-0.28 (-1.11%)
205
Hold Since 29-Apr-2024
$23
2 years 6 months 24 days ago
(29-Apr-2024)
5/8 (62.5%)
$8.58 (59.50%)
354
What is DCPH (Deciphera Pharmaceuticals LLC) average time for price targets to be met?
Which analyst most recently updated their price target on DCPH (Deciphera Pharmaceuticals LLC)?
Which analyst has the most public recommendations on DCPH (Deciphera Pharmaceuticals LLC)?
Which analyst is the currently most bullish on DCPH (Deciphera Pharmaceuticals LLC)?
Which analyst is the currently most reserved on DCPH (Deciphera Pharmaceuticals LLC)?